EFung Capital
Venture capitalShenzhen · Seed–Growth
Investment thesis
EFung Capital positions itself as an investment firm dedicated to the biomedical and healthcare sector in China. After repositioning to focus on biomedicine, it raised and deployed its first post-transition fund and increased investment in innovative medical technologies. The firm pursues coordinated domestic and overseas investment, seeking high-quality projects abroad, and has seen numerous portfolio companies list on capital markets. It established a Hainan-based private fund management entity registered with AMAC and, as one of the first signatory institutions, entered a strategic agreement with China's national venture capital guidance fund.
Source: firm website, verified Aug 3, 2026.
What they invest in
from 1 of 19 portfolio companiesBiotech ×1
HQs:United States×1
Investments · 19 tracked
founders shown can be your intro pathCentrexion is a pharmaceutical company developing drugs in two therapeutic areas: non-opioid pain relief and immunology.
BiotechBaltimore, US
Sol Barer(Director)Kerrie L. Brady(Executive Officer)James N. Campbell(Executive Officer, Director)Shengda Zan(Director)Gregg Beloff(Executive Officer)Arnold L. Oronsky(Director)
Frequently asked questions
- What stage does EFung Capital invest at?
- EFung Capital invests at the Seed, Series A, Series B, Series C, Growth stages.
- What sectors does EFung Capital focus on?
- EFung Capital focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is EFung Capital located?
- EFung Capital is headquartered in Shenzhen, CN.
Similar investors
Capricorn Venture Partners is a European investment firm managing several thematic funds across growth capital, healthcare, and cleantech, as well as a combined private/quoted investment vehicle.
The Novartis Venture Fund invests in innovative life science companies, focusing on biotechnology and biopharmaceuticals at various stages of growth, aiming to drive patient benefit and generate returns.
OneVentures is a later-stage venture capital firm that backs technology and healthcare companies, providing growth equity and credit alongside strategic and operational support.
Abingworth is a life science venture capital firm that backs early-stage biopharma and biotech companies, helping entrepreneurs translate scientific discoveries into new therapeutics.
EQT Life Sciences, formerly LSP, is one of Europe's largest and most experienced life sciences investors, backing companies developing therapeutics, medical devices, diagnostics and healthtech globally. It is part of EQT Group.